SGLTR M (Remogliflozin Etabonate (100mg) + Metformin (500mg))

SGLTR M is a medication commonly prescribed for managing high blood sugar levels in adults with type 2 diabetes. It combines two active ingredients, Remogliflozin Etabonate and Metformin, which work together to help control glucose levels. By doing so, it supports patients in maintaining a healthier lifestyle and reducing the risk of diabetes-related complications.

Remogliflozin Etabonate helps the kidneys remove excess sugar from the blood through urine, while Metformin primarily works by improving the body’s sensitivity to insulin and reducing sugar production in the liver. Together, they create a comprehensive approach to blood sugar management.

For optimal results, it is important to store SGLTR M in a cool, dry place, away from direct sunlight and moisture. Maintaining a consistent schedule when taking this medication can also be beneficial for blood sugar control. It is advisable to inform your healthcare provider about any other medications you are taking and to follow their recommendations closely to avoid potential interactions.

Some common, mild side effects may include nausea, diarrhea, or stomach upset. While these effects are generally not severe, it is essential to monitor how your body responds to the medication and to speak with your healthcare provider if you have concerns.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.